MIRA INFORM REPORT

 

 

Report Date :

18.12.2013

 

IDENTIFICATION DETAILS

 

Name :

LAWRANCE PHARMA (PVT) LIMITED (LPL)

 

 

Registered Office :

193 Circular Road, 2nd Floor, Bilal Market, Chowk New Anarkali, Lahore

 

 

Country :

Pakistan

 

 

Date of Incorporation :

29.06.1993

 

 

Com. Reg. No.:

0030672

 

 

Legal Form :

Private Limited company

 

 

Line of Business :

Manufacturer, Importer and Exporter of pharmaceutical products and raw material.

 

 

No. of Employees :

45

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

Unknown

Litigation :

Clear

 


 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Pakistan

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

PAKISTAN - ECONOMIC OVERVIEW

 

Decades of internal political disputes and low levels of foreign investment have led to slow growth and underdevelopment in Pakistan. Agriculture accounts for more than one-fifth of output and two-fifths of employment. Textiles account for most of Pakistan's export earnings, and Pakistan's failure to expand a viable export base for other manufactures has left the country vulnerable to shifts in world demand. Official unemployment is under 6%, but this fails to capture the true picture, because much of the economy is informal and underemployment remains high. Over the past few years, low growth and high inflation, led by a spurt in food prices, have increased the amount of poverty - the UN Human Development Report estimated poverty in 2011 at almost 50% of the population. Inflation has worsened the situation, climbing from 7.7% in 2007 to almost 12% for 2011, before declining to 10% in 2012. As a result of political and economic instability, the Pakistani rupee has depreciated more than 40% since 2007. The government agreed to an International Monetary Fund Standby Arrangement in November 2008 in response to a balance of payments crisis. Although the economy has stabilized since the crisis, it has failed to recover. Foreign investment has not returned, due to investor concerns related to governance, energy, security, and a slow-down in the global economy. Remittances from overseas workers, averaging about $1 billion a month since March 2011, remain a bright spot for Pakistan. However, after a small current account surplus in fiscal year 2011 (July 2010/June 2011), Pakistan's current account turned to deficit in fiscal year 2012, spurred by higher prices for imported oil and lower prices for exported cotton. Pakistan remains stuck in a low-income, low-growth trap, with growth averaging about 3% per year from 2008 to 2012. Pakistan must address long standing issues related to government revenues and energy production in order to spur the amount of economic growth that will be necessary to employ its growing and rapidly urbanizing population, more than half of which is under 22. Other long term challenges include expanding investment in education and healthcare, adapting to the effects of climate change and natural disasters, and reducing dependence on foreign donors

Source : CIA


Company name

 

LAWRANCE PHARMA (PVT) LIMITED (LPL)

 

 

GENERAL INFORMATION

 

Business Name

LAWRANCE PHARMA (PVT) LIMITED (LPL)

Address

Head Office / Registered Office:

193 Circular Road, 2nd Floor, Bilal Market, Chowk New Anarkali, Lahore.

Factory Address:

10-K.M- Sheikhpura Road, Lahore

Telephone

(+92) (42) 37230110, 37122065-69, 37920451  

Fax

(+92) (42) 37233537, 37916173

Mobile

(+92) (300) 4240049

Mr. M. Arif Siddiqui - Director

Email

marslan@brain.net.pk

Website

None

Business activities

Manufacturer, Importer and Exporter of pharmaceutical products and raw material.

 

 

Registry Details

CRO Registration Number

0030672

Date of Registration

June 29, 1993  

 

 

Other registry & certification details:

Current Legal Form

Private Limited company

National Tax Registration Number

0786297-7

Date of Registration

July 06, 2002

GST Registration Number

0300078629711

Date of Registration

June 04, 2013

Chamber of Commerce & Industry

Lahore Chamber of Commerce and Industry

Date of Registration

Undetermined

ISO Certification

None

Date of Registration

N/A

Other certifications

None

Date of Registration

N/A

 

 

Capital

Type

No. of Shares

Par Value

Total Value

Authorize Capital

130,000

Rs. 100/-

Rs. 13,000,000/-

Paid up Capital

70,330

Rs. 100/-

Rs. 7,033,000/-

 


History

Who started

Undetermined

When started

June 29, 1993  

Change in management

None

Year of change

N/A

Change in legal status

None

Year of change

N/A

Change in business address

None

Year of change

N/A

 

 

PRINCIPALS (SPONSORS)

 

Name

Designation

Number of Shares

Nationality

Appointment Date (Last)

Mr. Muhammad Arif

Director/C.E.O

26,624

Pakistani

30-06-2012

Muhammad Arsalan Arif

Director

17,082

Pakistani

30-06-2012

Muhammad Farrukh Arif

Director

13,312

Pakistani

30-06-2012

Muhammad Farhan Arif

Director

13,312

Pakistani

30-06-2012

 

 

KEY MANAGEMENT

 

Name

 

Position in organization

Qualification

Years in employment

Mr. Muhammad Arif

C.E.O

Not provided

Not provided

Mr. Muhammad Arsalan Arif

Director

Not provided

Not provided

Mr. Kashif

Manager Marketing

Not provided

Not provided

 

Statutory offices

 

Statutory Auditors

M/s. Karamat Ch. & Company Chartered Accountants

Legal Advisory Services

Ch. Abdul Waheed

 

 

BANKERS

 

Bank name

Approved financing limits

Habib Bank Limited

26,300,000

 

 

 

DETAILS OF BUSINESS ACTIVITIES

 

The primary focus of the LPL is manufacturing and trading of Pharmaceutical raw material and medicines, its product includes raw material, injectable and different syrups. Some of its products include:

 


Analgesics, antipyretics, NSAIDs, Antigout, and Antirheumatics (Category - 2)

 

L-PYRON

 

LAWRAMOL

 

WOODTRAN

 

 


Anti-allergics (Antihistamines) and drugs used in anaphylaxis (Category - 3)

 

PHENVIL

 

 

 

 


Anticonvulsants and Antiepileptics (Category - 5)

 

PHENOBARBITONE

 

 

 

 


Anti-infective drugs (Category - 6)

 

GENTAMYCIN

 

LAWRCIP

 

LAWRMYCIN

 

 

QUININE

 

QUININE HYDROCHLORIDE

 

LINCOMYCIN

 

 


Drugs affecting the blood (Category - 10)

 

LAWRGLUCONATE

 

 

 

 


Gastrointestinal drugs (Category - 17)

 

FAMOTIDINE

 

FURAZOLIDON

 

LAWRITIDINE

 

 

LESKOPAN

 

LAWRVINATE

 

 

 


Hormones and other endocrine drugs and contraceptives (Category - 18)

 

DEXAMETHASONE

 

 

 

 


Drugs acting on the respiratory tract (Category - 25)

 

LAWRCORT

 

 

 

 


Vitamins, minerals, tonics, and other substances (Category - 27)

 

CYANAMIN

 

LAWRPLEX

 

VITAMIN K

 

 

 

 

Purchases (Incl. Imports)

Imports from

Not Disclosed

Importing terms

Local (%)

Local buying terms

 

Sales (Incl. Exports)

Exports to

Not Disclosed

Exporting terms

Local (%)

Local selling terms

 

 

NUMBER OF EMPLOYEES

 

Nature of employment

Current Year

Previous Year

All Staff

45

45

Total

45

45

 

 

BUSINESS FACILITIES

 

Head office Address

Owned / Rented

Area (approx)

193 Circular Road, 2nd Floor, Bilal Market, Chowk New Anarkali, Lahore.

Details not provided.

Factory Address

Owned / Rented

Area (approx)

10-K.M- Sheikhpura Road, Lahore

Details not provided.

Warehouse Address

Owned / Rented

Area (approx)

No

 

 

MARKET REPUTATION

 

During the market check of LPL, we contacted various suppliers / customers / competitors of the subject company. In their opinion subject company is a good player of the industry and enjoys average reputation in the market. Market sources further mentioned that LPL is known as a profitable business in the industry.

 

 

DETAILS OF RELATED BUSINESSES (NOT PROVIDED)

 

Business Name

City

Line of Business

Percentile of Shareholding

Not Disclosed

 

 

BUSINESS PERFORMANCE

 

The contact person decline to share financial information.

 

 

INTERVIEW & REPORTER COMMENTS

 

Contact person

Mr. Kashif

Position

Manager Marketing

Comments

We visited the office premise of said company and Mr. Kashif confirmed operations but declined to share information regarding sales/purchase and financials of the company.

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.96

UK Pound

1

Rs.101.14

Euro

1

Rs.85.33

 

 

INFORMATION DETAILS

 

Report Prepared by :

NIS

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.